Rosalind and Morris Goodman Cancer Institute, Department of Physiology, McGill University, Montreal, Quebec, Canada.
Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20220011. Epub 2022 May 6.
Neutrophils are the first responders to infection and inflammation and are thus a critical component of innate immune defense. Understanding the behavior of neutrophils as they act within various inflammatory contexts has provided insights into their role in sterile and infectious diseases; however, the field of neutrophils in cancer is comparatively young. Here, we summarize key concepts and current knowledge gaps related to the diverse roles of neutrophils throughout cancer progression. We discuss sources of neutrophil heterogeneity in cancer and provide recommendations on nomenclature for neutrophil states that are distinct in maturation and activation. We address discrepancies in the literature that highlight a need for technical standards that ought to be considered between laboratories. Finally, we review emerging questions in neutrophil biology and innate immunity in cancer. Overall, we emphasize that neutrophils are a more diverse population than previously appreciated and that their role in cancer may present novel unexplored opportunities to treat cancer.
中性粒细胞是感染和炎症的第一反应者,因此是先天免疫防御的关键组成部分。了解中性粒细胞在各种炎症环境中的行为为其在无菌和感染性疾病中的作用提供了深入的了解;然而,癌症中性粒细胞领域相对较新。在这里,我们总结了与癌症进展过程中中性粒细胞的多种作用相关的关键概念和当前的知识空白。我们讨论了癌症中中性粒细胞异质性的来源,并就成熟和激活状态不同的中性粒细胞状态的命名提供了建议。我们解决了文献中的差异,强调需要在实验室之间考虑技术标准。最后,我们综述了癌症中性粒细胞生物学和先天免疫中的新问题。总的来说,我们强调中性粒细胞比以前认为的更为多样化,它们在癌症中的作用可能为治疗癌症提供新的、尚未开发的机会。